Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 726 of 6351
-
New hope for nerve disease patients: drug may replace monthly IV treatments
Disease control Recruiting nowThe purpose of the study is to evaluate efficacy of riliprubart compared to IVIg in adult participants with CIDP who are receiving maintenance treatment with IVIg. The study duration will be for a maximum of 109 weeks including screening, treatment phases, and follow-up.
Phase 3 • Sponsor: Sanofi • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
New study aims for Long-Term remission in Standard-Risk myeloma
Disease control OngoingThe purpose of this study is to evaluate the rate of response (how effectively treatment is working) with signs of potential cure at 5 years after the start of induction treatment. This is defined as a composite of sustained (at least 2 years) minimal residual disease (MRD) negat…
Phase 2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New psoriasis pill shows promise in major trial
Disease control CompletedThe goal of this clinical trial is to learn if ESK-001 works to treat moderate to severe plaque psoriasis. The main questions it aims to answer are: * Does ESK-001 reduce the severity of people's psoriasis? * How safe is ESK-001 in people with moderate to severe plaque psoriasis…
Phase 3 • Sponsor: Alumis Inc • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Herbal granules aim to slow Alzheimer's in major trial
Disease control Recruiting nowThis study is a randomized, double-blind, placebo-controlled phase 3 design aimed at further verifying the safety and efficacy of Wujia Yizhi granules for mild-to-moderate Alzheimer's dementia
Phase 3 • Sponsor: Sichuan Jishengtang Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New ultrasound technique could spot hidden liver cancers
Diagnosis Recruiting nowWorldwide, liver cancers are the third most common cause of cancer mortality. Even when liver cancer is suspected by blood tests, imaging is required to determine the location, size, and extent of disease. Medical societies therefore recommend surveillance with ultrasound every 6…
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Diagnosis
Last updated Jun 27, 2026 11:03 UTC
-
Could stem cells offer new hope for autoimmune lung damage?
Disease control Recruiting nowConnective tissue disease (CTD), an autoimmune and inflammatory disease, usually accompanied by lung interstitial/alveolar inflammation and fibrosis (so called interstitial lung disease, ILD). The prevalence and mortality rate of CTD-ILD increase in recent several years. Although…
Phase 1/2 • Sponsor: China Medical University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Can writing about suicidal thoughts save lives? new trial aims to find out
Symptom relief Recruiting nowMilitary service members admitted to inpatient psychiatry for self-injurious thoughts and behaviors (SITBs) represent an at-risk group for continued SITBs and rehospitalizations in the post-discharge period. However, there is an absence of evidence-based interventions designed to…
Sponsor: Boston University • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Ancient Mind-Body practice put to the test for spinal cord injury pain
Symptom relief Recruiting nowChronic neuropathic pain affects 69% of adults with spinal cord injury (SCI). Current treatment options are limited (primarily pain medications) with insufficient benefits and significant risks for addiction and adverse effects. Of the available mind and body approaches, Qigong i…
Sponsor: University of Minnesota • Aim: Symptom relief
Last updated Aug 21, 2026 00:00 UTC
-
New Clot-Busting device could change how we treat dangerous lung clots
Disease control Recruiting nowThis is a prospective, multi-center, pivotal study to demonstrate the safety and effectiveness of the Laguna Thrombectomy System for the treatment of pulmonary embolism. The Laguna Thrombectomy System is an investigational device which consists of the Laguna Clot Retriever™ Syste…
Sponsor: Innova Vascular, Inc. • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Diabetes drug may protect the brain: canagliflozin tested for cognitive decline
Disease control Recruiting nowThe prevalence of cognitive dysfunction in diabetic patients is high, which seriously affects the quality of life of patients, and early intervention is of great significance. Central nervous system insulin resistance plays a key role in the pathogenesis of cognitive dysfunction …
Phase 4 • Sponsor: Fudan University • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Could less radiation be just as effective for HPV throat cancer?
Disease control Recruiting nowThe researchers are doing this study to find out if a personalized approach to chemoradiation therapy (which may include a lower dose of radiation) is as effective as the standard chemoradiation therapy in people with HPV-positive throat cancer. Other purposes of this study inclu…
Phase 3 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Magic mushroom compound tested for Parkinson's depression
Symptom relief Recruiting nowThe purpose of this study is to understand whether people with Parkinson's Disease and depression have improvement in their symptoms after psilocybin therapy.
Phase 2 • Sponsor: Joshua Woolley, MD, PhD • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
New hope for tiny tummies: drug trial targets deadly infant gut disease
Disease control Recruiting nowThe primary objective of this study is to determine the safety and tolerability of two dose levels (0.5 mL/kg and 1.0 mL/kg) of once daily (QD) via IV route of administration of ST266 in treating patients with Bell's stage IIA or higher medical NEC by incidence of treatment emerg…
Phase 1/2 • Sponsor: Noveome Biotherapeutics, formerly Stemnion • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Simple handwashing program could curb cholera outbreaks
Prevention Recruiting nowThe findings from previous recent randomized controlled trials of The Cholera Hospital Based Intervention for 7 Days (CHoBI7) demonstrated that this intervention was effective in significantly reducing symptomatic cholera infections, diarrheal disease, and stunting among young ch…
Sponsor: Johns Hopkins Bloomberg School of Public Health • Aim: Prevention
Last updated Jun 27, 2026 12:08 UTC
-
New stroke treatment shows promise in early trial
Disease control Recruiting nowOur main hypothesis is that acute EVT associated with best medical treatment is superior to best medical treatment alone, for improving clinical outcomes at 90 days, in patients with mild or severe acute ischemique stroke and diffusion-perfusion or clinical-imaging mismatch, seco…
Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New pill vs. injection: which works better for kids with severe eczema?
Disease control Recruiting nowAtopic dermatitis (AD) is a skin condition that may cause a rash and itching due to inflammation of the skin. Topical therapies applied over the skin may not be enough to control the AD in trial participants who require systemic anti-inflammatory treatment. This study compares up…
Phase 3 • Sponsor: AbbVie • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Poop pills vs. superbugs: can a fecal transplant clear Drug-Resistant bacteria?
Disease control OngoingThis is a randomized, open label, comparative Phase II trial being conducted to determine whether fecal microbiota transplant using Penn Microbiome Therapy (PMT) products helps standard therapy eradicate antibiotic-resistant bacteria.
Phase 2 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Immunotherapy cocktail shows promise against tough rectal cancers
Disease control CompletedThe objective is to evaluate whether the neoadjuvant combination of tislelizumab (a PD-1 inhibitor) with interleukin-2 (IL-2) chemotherapy can significantly increase the Objective Response Rate (ORR) and the Pathological Complete Response rate (pCR) in patients with locally advan…
Phase 2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New drug trial hopes to shrink tumors in kids with Hard-to-Treat cancers
Disease control Recruiting nowSubstudy 01A is part of a platform study. The purpose of this study is to assess the efficacy and safety of zilovertamab vedotin in pediatric participants with relapsed or refractory B-cell acute lymphoblastic leukemia (B-ALL), diffuse large B-cell lymphoma (DLBCL)/Burkitt lympho…
Phase 1/2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Herbal cream could heal diabetic foot wounds without surgery
Disease control OngoingThis is a phase II/III seamless design, randomized, double-blind, paralleled-group, placebo-controlled study to evaluate the efficacy and safety of Xianglei Tangzu Gao for the treatment of Wagner grade II diabetic foot ulcers. The primary endpoint is the proportion of subjects wi…
Phase 2/3 • Sponsor: Oneness Biotech Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC